DK Life Science Co., Ltd. (KOSDAQ:303810)
South Korea · Delayed Price · Currency is KRW 3,690.00
+290.00 (8.53%)
Apr 1, 2026, 3:30 PM KST
DK Life Science Revenue
In the year 2025, DK Life Science had annual revenue of 130.34B KRW, down -1.12%. DK Life Science had revenue of 30.97B in the quarter ending December 31, 2025, a decrease of -2.60%.
Revenue
130.34B
Revenue Growth
-1.12%
P/S Ratio
0.91
Revenue / Employee
1.30B
Employees
100
Market Cap
118.02B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 130.34B | -1.47B | -1.12% |
| Dec 31, 2024 | 131.82B | 11.65B | 9.70% |
| Dec 31, 2023 | 120.16B | 12.93B | 12.05% |
| Dec 31, 2022 | 107.23B | 4.57B | 4.45% |
| Dec 31, 2021 | 102.67B | -6.91B | -6.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Biologics | 4.56T |
| Celltrion | 4.16T |
| Ildong Holdings | 590.89B |
| Sam Chun Dang Pharm. | 231.81B |
| ALTEOGEN | 202.18B |
| CKD Bio | 159.93B |
| Osang Healthcare Co.,Ltd | 128.63B |
| LabGenomics | 89.36B |